Use of N-alkylamino-heterocylic compounds for the treatment of migraine
US6635639B2 · kind B2 · utility
14Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2002 |
| Grant date | Oct 21, 2003 |
| Priority date | — |
| Expiry date | Mar 6, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are compounds having formula I or II: wherein:X is N, andAk represents a C1-3 alkylene chain;and a salt, solvate or prodrug thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.